Aids Policy and Pharmaceutical Patents: Brazil's Strategy to Safeguard Public Health

20 Pages Posted: 4 Feb 2005

See all articles by Jillian Clare Cohen

Jillian Clare Cohen

University of Toronto - Leslie Dan Faculty of Pharmacy

Kristina M.L. Acri née Lybecker

Colorado College - Department of Economics & Business

Abstract

Developing nations are challenged to strike a balance between their patent obligations as members of the World Trade Organisation (WTO) and their drug pricing strategies. The Brazilian approach to pharmaceutical price negotiations has been strikingly effective. Describing the context of the Brazilian pharmaceutical sector, their public health system and the Brazilian AIDS policy, this paper examines the Brazilian strategy vis-a-vis the international pharmaceutical manufacturers to explore why their tactics were successful and the potential for wider application by other developing countries.

Suggested Citation

Cohen, Jillian Clare and Acri née Lybecker, Kristina M.L., Aids Policy and Pharmaceutical Patents: Brazil's Strategy to Safeguard Public Health. The World Economy, Vol. 28, No. 2, pp. 211-230, February 2005. Available at SSRN: https://ssrn.com/abstract=660666

Jillian Clare Cohen (Contact Author)

University of Toronto - Leslie Dan Faculty of Pharmacy ( email )

Toronto, Ontario M5S 3E6 M5S 3G8
Canada
416 946-8708 (Phone)

Kristina M.L. Acri née Lybecker

Colorado College - Department of Economics & Business ( email )

14 E Cache La Poudre Street
Colorado Springs, CO 80903
United States
719-389-6445 (Phone)
719-389-6927 (Fax)

Register to save articles to
your library

Register

Paper statistics

Downloads
25
Abstract Views
1,424
PlumX Metrics
!

Under construction: SSRN citations will be offline until July when we will launch a brand new and improved citations service, check here for more details.

For more information